- Citations, last 5 years
- 196.4k
- Works, last 5 years
- 25.2k
- h-index
- 970
- Scientists listed
- 3 208
- Grants since 2016
- 4 385
Grants received
2022–2027 · research · R35
Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology
Joseph R. Lakowicz · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Mechanisms of microbiome-driven cardiac allograft outcomes
Jonathan S Bromberg · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
Amit Sawant · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Mechanisms coordinating the local and systemic resistance to pathogens
Nevil John Singh · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Effects of Attachment-Based Intervention on Low-Income Latino Children's Emerging Health Outcomes: A Randomized Controlled Trial
Lisa J Berlin · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2025 · research · R56
Targeting PI3Kalpha beta and the ErbB family of protein-tyrosine kinases in cisplatin-resistant head and neck squamous cell carcinomas (HNSCC)
Kevin J. Cullen · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2024 · research · R01
Regulation of Osteoblast Metabolism by Lrp5
Ryan C Riddle · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2024 · fellowship · F32
Investigating the ventral pallidum-ventral tegmental area circuit in cocaine relapse
Rianne Campbell · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Behavioral and neural mechanisms mediating social motivation in a rat model for ASD
Marco Venniro · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer
Taofeek K Owonikoko · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
Manhattan E Charurat · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R35
Photonics-based Fluorescence Imaging for Research, Diagnostics, and Pathology
Joseph R. Lakowicz · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2023 · research · R56
A novel continuous real-time non-invasive CO2 monitor to help prevent death in the underserved minority population from opioid overdose
Xudong Ge · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
The role of optic nerve lamina region stem cells in age-related optic nerve disease
Steven L Bernstein · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R01
Trauma and Shock-Induced Microvascular Dysregulation and Coagulopathy
Jing-Fei Dong · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
University of Maryland FIRST Program
James B Kaper · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Genomic profiling mediating the protective effect of social reward on opioid craving
Seth Abrams Ament · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Improving Brain Recovery Through Glycoengineering
Xiaofeng Jia · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R33
Cell-type and organelle-specific multi-omics platform for the study of brain aging
Michael P Cummings · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R01
Combining innovative molecular adjuvanting approaches with novel adenoviral vector delivery to generate a universal influenza vaccine
Lynda Coughlan · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Multi-scale consequences of variants in the schizophrenia risk gene SETD1A in a population isolate.
Seth Abrams Ament · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Recovery among Older Adults Following Head Injury
Jennifer S. Albrecht · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2023 · research · R21
L1 element mutagenesis as a driver of epithelial cancers in African Americans
Scott E Devine · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2024 · research · R21
Expanding the Pathogenic Mechanisms of Calmodulinopathies
Ivy E Dick · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2025 · research · R01
Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria
Manhattan E Charurat · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
The role of optic nerve lamina region stem cells in age-related optic nerve disease
Steven L Bernstein · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2025 · research · R37
KPTN Loss and Megalencephaly: mTOR Activation as Therapeutic Target
Peter B Crino · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · training · T32
Systems-Level Research in Microbial Pathogenesis
Nicholas H Carbonetti · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2024 · research · R61
Self-test HIV diagnostics utilizing structurally novel, shark-derived binding domains
Helen M. Dooley · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Integrated Model for the Prevention of Anal Cancer using screen and Treat for HSIL (IMPACT)
Sylvia Adebajo · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R33
Prebiotic Treatment in People with Schizophrenia
Robert W Buchanan · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2023 · research · R36
Socioeconomic and Microenvironmental Factors Associated with the Vaginal Microbiota in Peri- and Post- Menopausal Women
Christina Stennett · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R01
Computational Modeling of Device-Induced Platelet Activation and Receptor Shedding Relevant to Thrombosis and Bleeding in Device-Assisted Circulation
Zhongjun Jon Wu · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R01
Comparing Direct and Indirect Methods for Cascade Screening in Familial Hypercholesterolemia (FH) and Long QT Syndrome (LQTS)
Amber L Beitelshees · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
Manhattan E Charurat · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2027 · research · R01
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
David Serre · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · cooperative agreement · UG3
PTPRD phosphatase inhibitors for stimulant use disorders
George Richard Uhl · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2026 · research · R01
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
Rebecca M. Brotman · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2024 · research · R21
Metabolic imaging of hyperpolarized 13C pyruvate in polycystic kidney disease
Dirk Mayer · University of Maryland, Baltimore · funded by National Institutes of Health
2022–2025 · training · T32
UMB IMSD
Amanda Gail Oglesby · University of Maryland, Baltimore · funded by National Institutes of Health
